PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition

Li Ting Wang, Kwei Yan Liu, Wen Yih Jeng, Cheng Ming Chiang, Chee Yin Chai, Shyh Shin Chiou, Ming Shyang Huang, Kazunari K. Yokoyama, Shen Nien Wang, Shau Ku Huang, Shih Hsien Hsu

研究成果: Article同行評審

32 引文 斯高帕斯(Scopus)


Epigenetic regulation is important for cancer progression; however, the underlying mechanisms, particularly those involving protein acetylation, remain to be fully understood. Here, we show that p300/CBP-associated factor (PCAF)-dependent acetylation of the transcription factor intestine-specific homeobox (ISX) regulates epithelial–mesenchymal transition (EMT) and promotes cancer metastasis. Mechanistically, PCAF acetylation of ISX at lysine 69 promotes the interaction with acetylated bromodomain-containing protein 4 (BRD4) at lysine 332 in tumor cells, and the translocation of the resulting complex into the nucleus. There, it binds to promoters of EMT genes, where acetylation of histone 3 at lysines 9, 14, and 18 initiates chromatin remodeling and subsequent transcriptional activation. Ectopic ISX expression enhances EMT marker expression, including TWIST1, Snail1, and VEGF, induces cancer metastasis, but suppresses E-cadherin expression. In lung cancer, ectopic expression of PCAF–ISX–BRD4 axis components correlates with clinical metastatic features and poor prognosis. These results suggest that the PCAF–ISX–BRD4 axis mediates EMT signaling and regulates tumor initiation and metastasis.

期刊EMBO Reports
出版狀態Published - 2020 2月 5

All Science Journal Classification (ASJC) codes

  • 生物化學
  • 分子生物學
  • 遺傳學


深入研究「PCAF-mediated acetylation of ISX recruits BRD4 to promote epithelial-mesenchymal transition」主題。共同形成了獨特的指紋。